Greenleaf Trust Purchases 231 Shares of Agilent Technologies, Inc. (NYSE:A)

Greenleaf Trust boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,036 shares of the medical research company’s stock after buying an additional 231 shares during the quarter. Greenleaf Trust’s holdings in Agilent Technologies were worth $1,080,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in A. McAdam LLC raised its position in shares of Agilent Technologies by 3.1% during the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock worth $376,000 after acquiring an additional 77 shares during the last quarter. Brown Brothers Harriman & Co. raised its holdings in Agilent Technologies by 13.5% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after purchasing an additional 77 shares during the last quarter. Global Retirement Partners LLC lifted its position in shares of Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock worth $382,000 after purchasing an additional 79 shares during the period. Rovin Capital UT ADV boosted its stake in shares of Agilent Technologies by 1.6% in the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after purchasing an additional 81 shares during the last quarter. Finally, Marshall Financial Group LLC increased its position in shares of Agilent Technologies by 1.0% during the third quarter. Marshall Financial Group LLC now owns 8,243 shares of the medical research company’s stock worth $1,224,000 after buying an additional 82 shares during the period. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have commented on A. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research report on Monday, December 9th. Citigroup raised their target price on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Bank of America reduced their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Finally, Barclays dropped their target price on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research report on Wednesday, November 27th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $143.62.

Agilent Technologies Trading Down 1.9 %

A opened at $148.69 on Tuesday. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The firm has a market capitalization of $42.47 billion, a PE ratio of 33.64, a P/E/G ratio of 4.10 and a beta of 1.06. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The company’s 50-day moving average is $140.52 and its 200 day moving average is $138.85.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.38 earnings per share. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were paid a $0.248 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.67%. Agilent Technologies’s dividend payout ratio is presently 22.40%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.33% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.